Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 8929 [2021-02688]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 26 / Wednesday, February 10, 2021 / Notices
The DG, entitled, ‘‘Safety-Related
Steel Structures and Steel-Plate
Composite Walls for other than Reactor
Vessels and Containments’’ is a
proposed new guide temporarily
identified by its task number, DG–1304.
It proposes guidance to meet regulatory
requirements for safety-related steel
structures and steel-plate composite
walls for other than reactor vessels and
containments. It endorses with,
exceptions and clarifications, the 2018
edition of ANSI/AISC N690–2018,
‘‘Specification for Safety-Related Steel
Structures for Nuclear Facilities.’’
The staff is also issuing for public
comment a draft regulatory analysis
(ADAMS Accession No. ML20339A559).
The staff develops a regulatory analysis
to assess the value of issuing or revising
a regulatory guide as well as alternative
courses of action.
III. Backfitting, Forward Fitting, and
Issue Finality
Issuance of DG–1304, if finalized,
would not constitute backfitting as that
term is defined in title 10 of the Code
of Federal Regulations (10 CFR) section
50.109, ‘‘Backfitting,’’ and as described
in NRC Management Directive 8.4,
‘‘Management of Backfitting, Forward
Fitting, Issue Finality, and Information
Requests’’; constitute forward fitting as
that term is defined and described in
MD 8.4; or affect issue finality of any
approval issued under 10 CFR part 52,
‘‘Licenses, Certificates, and Approvals
for Nuclear Power Plants.’’ As explained
in DG–1304, applicants and licensees
are not required to comply with the
positions set forth in DG–1361.
Dated: February 4, 2021.
For the Nuclear Regulatory Commission.
Meraj Rahimi,
Chief, Regulatory Guidance and Generic
Issues Branch, Division of Engineering, Office
of Nuclear Regulatory Research.
[FR Doc. 2021–02720 Filed 2–9–21; 8:45 am]
BILLING CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
Advisory Committee on the Medical
Uses of Isotopes: Meeting Notice
U.S. Nuclear Regulatory
Commission.
ACTION: Notice of meeting.
AGENCY:
The U.S. Nuclear Regulatory
Commission (NRC) will convene a
meeting of the Advisory Committee on
the Medical Uses of Isotopes (ACMUI)
on March 16, 2021. A sample of agenda
items to be discussed during the public
session includes: An overview of fiscal
SUMMARY:
VerDate Sep<11>2014
18:53 Feb 09, 2021
Jkt 253001
year 2020 medical related events; a
discussion on the status of the NRC’s
patient release evaluation of emerging
brachytherapy sources; a discussion on
calibration procedures for existing and
emerging brachytherapy sources; a
discussion on the current ACMUI
reporting structure; and an overview on
the consequences of
radiopharmaceutical extravasation and
therapeutic interventions in nuclear
medicine. The agenda is subject to
change. The current agenda and any
updates will be available on the
ACMUI’s Meetings and Related
Documents web page at https://
www.nrc.gov/reading-rm/doccollections/acmui/meetings/2021.html
or by emailing Ms. Kellee Jamerson at
the contact information below.
DATES: Date and Time for Open Session:
Tuesday, March 16, 2021, from 10:00
a.m. to 3:45 p.m. EST.
ADDRESSES:
Date
March 16,
2021.
Webinar information
Link: https://
usnrc.webex.com.
Event number: 199 910
9533.
Public Participation: Due to the
ongoing COVID–19 public health
emergency, the meeting will be held as
a webinar using Cisco WebEx. Any
member of the public who wishes to
participate in any portion of this
meeting should register in advance of
the meeting by accessing the provided
link above. Upon successful registration,
a confirmation email will be generated
providing the telephone bridge line and
a link to join the webinar on the day of
the meeting. Members of the public
should also monitor the NRC’s Public
Meeting Schedule at https://
www.nrc.gov/pmns/mtg for any meeting
updates. If there are any questions
regarding the meeting, persons should
contact Ms. Jamerson using the
information below.
FOR FURTHER INFORMATION CONTACT: Ms.
Kellee Jamerson, email:
Kellee.Jamerson@nrc.gov, telephone:
301–415–7408.
SUPPLEMENTARY INFORMATION:
Purpose: Discuss issues related to 10
CFR part 35 Medical Use of Byproduct
Material.
Conduct of the Meeting
The ACMUI Chair, Darlene F. Metter,
M.D., will preside over the meeting. Dr.
Metter will conduct the meeting in a
manner that will facilitate the orderly
conduct of business. The following
procedures apply to public participation
in the meeting:
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
8929
1. Persons who wish to provide a
written statement should submit an
electronic copy to Ms. Jamerson using
the contact information listed above. All
submittals must be received by the close
of business on March 10, 2021 and must
only pertain to the topics on the agenda.
2. Questions and comments from
members of the public will be permitted
during the meeting, at the discretion of
the ACMUI Chairman.
3. The draft transcript and meeting
summary will be available on ACMUI’s
website https://www.nrc.gov/readingrm/doc-collections/acmui/meetings/
2021.html on or about May 3, 2021.
4. Persons who require special
services, such as those for the hearing
impaired, should notify Ms. Jamerson of
their planned participation.
This meeting will be held in
accordance with the Atomic Energy Act
of 1954, as amended (primarily Section
161a); the Federal Advisory Committee
Act (5 U.S.C. App); and the
Commission’s regulations in Title 10 of
the Code of Federal Regulations, Part 7.
Dated at Rockville, Maryland this 4th day
of February, 2021.
For the U.S. Nuclear Regulatory
Commission.
Russell E. Chazell,
Federal Advisory Committee Management
Officer.
[FR Doc. 2021–02688 Filed 2–9–21; 8:45 am]
BILLING CODE 7590–01–P
OFFICE OF PERSONNEL
MANAGEMENT
Submission for Review: 3206–0156,
Application for Death Benefits Under
the Civil Service Retirement System
(SF 2800); Documentation in Support
of Application for Death Benefits When
Deceased Was an Employee at the
Time of Death (CSRS)
Office of Personnel
Management.
ACTION: 60-Day notice and request for
comments.
AGENCY:
Retirement Services, Office of
Personnel Management (OPM) offers the
general public and other federal
agencies the opportunity to comment on
a renewal with minor edits of
information collection request (ICR), SF
2800—Application for Death Benefits
(CSRS) and SF 2800A—Documentation
and Elections in Support of Application
for Death Benefits When Deceased Was
an Employee at the Time of Death
(CSRS). We have updated the way we
display the OMB control number and
there are editorial changes to the
SUMMARY:
E:\FR\FM\10FEN1.SGM
10FEN1
]]>Agencies
[Federal Register Volume 86, Number 26 (Wednesday, February 10, 2021)]
[Notices]
[Page 8929]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-02688]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a
meeting of the Advisory Committee on the Medical Uses of Isotopes
(ACMUI) on March 16, 2021. A sample of agenda items to be discussed
during the public session includes: An overview of fiscal year 2020
medical related events; a discussion on the status of the NRC's patient
release evaluation of emerging brachytherapy sources; a discussion on
calibration procedures for existing and emerging brachytherapy sources;
a discussion on the current ACMUI reporting structure; and an overview
on the consequences of radiopharmaceutical extravasation and
therapeutic interventions in nuclear medicine. The agenda is subject to
change. The current agenda and any updates will be available on the
ACMUI's Meetings and Related Documents web page at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2021.html or by emailing Ms.
Kellee Jamerson at the contact information below.
DATES: Date and Time for Open Session: Tuesday, March 16, 2021, from
10:00 a.m. to 3:45 p.m. EST.
ADDRESSES:
------------------------------------------------------------------------
Date Webinar information
------------------------------------------------------------------------
March 16, 2021............................ Link: https://usnrc.webex.com.
Event number: 199 910 9533.
------------------------------------------------------------------------
Public Participation: Due to the ongoing COVID-19 public health
emergency, the meeting will be held as a webinar using Cisco WebEx. Any
member of the public who wishes to participate in any portion of this
meeting should register in advance of the meeting by accessing the
provided link above. Upon successful registration, a confirmation email
will be generated providing the telephone bridge line and a link to
join the webinar on the day of the meeting. Members of the public
should also monitor the NRC's Public Meeting Schedule at https://www.nrc.gov/pmns/mtg for any meeting updates. If there are any
questions regarding the meeting, persons should contact Ms. Jamerson
using the information below.
FOR FURTHER INFORMATION CONTACT: Ms. Kellee Jamerson, email:
[email protected], telephone: 301-415-7408.
SUPPLEMENTARY INFORMATION:
Purpose: Discuss issues related to 10 CFR part 35 Medical Use of
Byproduct Material.
Conduct of the Meeting
The ACMUI Chair, Darlene F. Metter, M.D., will preside over the
meeting. Dr. Metter will conduct the meeting in a manner that will
facilitate the orderly conduct of business. The following procedures
apply to public participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Ms. Jamerson using the contact information listed
above. All submittals must be received by the close of business on
March 10, 2021 and must only pertain to the topics on the agenda.
2. Questions and comments from members of the public will be
permitted during the meeting, at the discretion of the ACMUI Chairman.
3. The draft transcript and meeting summary will be available on
ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2021.html on or about May 3, 2021.
4. Persons who require special services, such as those for the
hearing impaired, should notify Ms. Jamerson of their planned
participation.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily Section 161a); the Federal Advisory
Committee Act (5 U.S.C. App); and the Commission's regulations in Title
10 of the Code of Federal Regulations, Part 7.
Dated at Rockville, Maryland this 4th day of February, 2021.
For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2021-02688 Filed 2-9-21; 8:45 am]
BILLING CODE 7590-01-P
